BIOMAT Database Logo BIOMAT Database Logo

Naturally occurring N(6)-substituted adenosines (cytokinin ribosides) are in vitro inhibitors of platelet aggregation: an in silico evaluation of their interaction with the P2Y(12) receptor. 2014

Giulio Vistoli, and Andrea Brizzolari, and Elena Faioni, and Cristina Razzari, and Enzo Santaniello
Department of Pharmaceutical Science, Università degli Studi, Via Celoria 2, 20100 Milano, Italy.

A few naturally occurring N(6)-substituted adenosine derivatives (cytokinin ribosides) were investigated as inhibitors of platelet aggregation induced in vitro by collagen and their activity range was demonstrated (IC50: 6.77-141 μM). A docking study suggests that anti-aggregation activity of these compounds could involve an interaction with the P2Y12 receptor binding site.

UI MeSH Term Description Entries
D010937 Plant Growth Regulators Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins. Phytohormone,Phytohormones,Plant Growth Regulator,Plant Hormone,Plant Hormones,Growth Regulators, Plant,Regulators, Plant Growth,Growth Regulator, Plant,Hormone, Plant,Hormones, Plant,Regulator, Plant Growth
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003583 Cytokinins Plant hormones that promote the separation of daughter cells after mitotic division of a parent cell. Frequently they are purine derivatives. Cytokinin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000244 Adenosine Diphosphate Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. ADP,Adenosine Pyrophosphate,Magnesium ADP,MgADP,Adenosine 5'-Pyrophosphate,5'-Pyrophosphate, Adenosine,ADP, Magnesium,Adenosine 5' Pyrophosphate,Diphosphate, Adenosine,Pyrophosphate, Adenosine
D012263 Ribonucleosides Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
D058906 Purinergic P1 Receptor Agonists Compounds that bind to and stimulate PURINERGIC P1 RECEPTORS. Adenosine Receptor Agonists,P1 Purinoceptor Agonists,Agonists, Adenosine Receptor,Agonists, P1 Purinoceptor,Purinoceptor Agonists, P1,Receptor Agonists, Adenosine

Related Publications

Giulio Vistoli, and Andrea Brizzolari, and Elena Faioni, and Cristina Razzari, and Enzo Santaniello
Platelet aggregation inhibitors. 4. N 6 -substituted adenosines.
April 1973, Journal of medicinal chemistry,
Giulio Vistoli, and Andrea Brizzolari, and Elena Faioni, and Cristina Razzari, and Enzo Santaniello
Platelet aggregation inhibitors. 2. Inhibition of platelet aggregation by 5'-, 2-, 6-, and 8-substituted adenosines.
April 1972, Journal of medicinal chemistry,
Giulio Vistoli, and Andrea Brizzolari, and Elena Faioni, and Cristina Razzari, and Enzo Santaniello
Evaluation of the radical scavenging activity of some representative isoprenoid and aromatic cytokinin ribosides (N6-substituted adenosines) by in vitro chemical assays.
December 2022, Natural product research,
Giulio Vistoli, and Andrea Brizzolari, and Elena Faioni, and Cristina Razzari, and Enzo Santaniello
Adenosine kinase of sarcoma 180 cells N 6 -substituted adenosines as substrates and inhibitors.
November 1971, Molecular pharmacology,
Giulio Vistoli, and Andrea Brizzolari, and Elena Faioni, and Cristina Razzari, and Enzo Santaniello
Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood.
November 2001, Platelets,
Giulio Vistoli, and Andrea Brizzolari, and Elena Faioni, and Cristina Razzari, and Enzo Santaniello
Thiophenes-Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors.
February 2022, Plants (Basel, Switzerland),
Giulio Vistoli, and Andrea Brizzolari, and Elena Faioni, and Cristina Razzari, and Enzo Santaniello
[Synthesis of new platelet aggregation inhibitors substituted with pyridylisoxazoles and their 4,5-dihydroanalogs].
December 1995, Bioorganicheskaia khimiia,
Giulio Vistoli, and Andrea Brizzolari, and Elena Faioni, and Cristina Razzari, and Enzo Santaniello
In vitro evaluation of inhibitors of platelet release and aggregation.
August 1975, Archives of surgery (Chicago, Ill. : 1960),
Giulio Vistoli, and Andrea Brizzolari, and Elena Faioni, and Cristina Razzari, and Enzo Santaniello
Pyridazines. XIII. Synthesis of 6-aryl-5-oxygenated substituted-3(2H)-pyridazinones and evaluation as platelet aggregation inhibitors.
July 1997, Chemical & pharmaceutical bulletin,
Giulio Vistoli, and Andrea Brizzolari, and Elena Faioni, and Cristina Razzari, and Enzo Santaniello
Patients with congenital abnormality of platelet aggregation induced by Ca(2+) ionophores may have a defect of the platelet P2Y(12) receptor for ADP.
November 2001, British journal of haematology,
Copied contents to your clipboard!